How Glenmark convinced its investors to back its high-risk R&D strategy

While earlier attempts were unsuccessful, with Glenmark running into huge losses, there seems to be growing consensus that the drugmaker’s R&D strategy makes it a different company. Perhaps even a valuable one.

11 February, 202510 min
0
How Glenmark convinced its investors to back its high-risk R&D strategy

You may also like

Business
Story image

The 72 hours that saw IndiGo unravel

A crew crunch, new regulatory norms and simmering discontent push India’s biggest airline into its biggest crisis yet, one that could seriously dent its reputation for reliability.

Business
Story image

India takes an unapologetic stand at COP30

As talks harden, India drags finance and fairness into the conversation at the annual climate summit.

Business
Story image

Metro Brands’ premium shoes start to pinch

Revenue growth slows for the footwear company as consumption skids and rivals crowd the market.